15-min delayed · Jul 28, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 13 firms covering TransUnion, 7 rate it Buy or better, 6 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. Targets are tightly clustered, $77.00 to $105.00, so the covering firms are broadly aligned. The average target of $87.92 sits 5% above the current $83.82. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $1.23 next quarter toward $5.59 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS13 ratings
Moderate Buy
Strong Buy00%
Buy754%
Hold646%
Sell00%
Strong Sell00%
Based on 13 analysts giving stock ratings to TransUnion.
As of Jul, 7 of 13 firms rate TRU a Buy (6 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
TRU EPS & revenue forecast
EPS · NEXT QUARTER
$1.23
Range $1.18 – $1.32 · 18 analysts · +12% YoY
Next period, 18 analysts expect TransUnion to earn $1.23 a share (range $1.18 – $1.32), versus $1.10 a year earlier. Full-year consensus is $4.78, growing to $5.59 the year after.
REVENUE · NEXT QUARTER
$1.3B
Range $1.3B – $1.3B · 18 analysts · +12% YoY
Revenue is expected to reach $1.3B (range $1.3B – $1.3B), +11.6% year-over-year. Full-year consensus is $5.1B, rising to $5.6B next year.
Top analysts covering TransUnion
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on TRU.
#1
Manav Patnaik
Barclays · Rank #113
Hold
$80.00-4.6% to target
Overall win rate
41%
+ Follow
#2
Jeffrey Silber
BMO Capital · Rank #269
Buy
$85.00+1.4% to target
Overall win rate
31%
+ Follow
#3
George Tong
Goldman Sachs · Rank #293
Hold
$75.00-10.5% to target
Overall win rate
33%
+ Follow
#4
Kyle Peterson
Needham · Rank #366
Buy
$95.00+13.3% to target
Overall win rate
25%
+ Follow
#5
Kevin Mcveigh
UBS
Hold
$77.00-8.1% to target
Coverage
—
+ Follow
TRU stock forecast FAQ
What is TRU's average 12-month price target?+
The 12 analysts with a live target average $87.92 for TransUnion over the next 12 months, ranging from a $105.00 high to a $77.00 low.
Is TRU stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 13 analyst ratings, 7 are Buy or Strong Buy, 6 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for TRU?+
The Street-high target is $105.00 (BMO Capital), and the Street-low is $77.00 (Mizuho). The average of all 12 active targets is $87.92.
How many Wall Street analysts cover TRU?+
13 analysts have an active rating on TransUnion, and 12 firms carry a live 12-month price target.
Who is the most accurate analyst covering TRU?+
Among analysts who currently cover TRU, Manav Patnaik of Barclays has the strongest overall Quantellect track record (Rank #113). Their current call is Hold with a $80.00 target.
What is TransUnion's projected EPS for next quarter?+
The consensus estimate is $1.23 per share (range $1.18 – $1.32) across 18 analysts. Full-year EPS is projected at $4.78, rising to $5.59 the following year.
How much revenue is TransUnion expected to report next quarter?+
Consensus revenue is $1.3B (range $1.3B – $1.3B). Full-year revenue is projected at $5.1B, growing to $5.6B next year.
Have analysts been upgrading or downgrading TRU lately?+
As of Jul, 7 of 13 firms rate TRU a Buy (6 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their TRU calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
